Last reviewed · How we verify

NCT03869775: PI

Perfusion Index Changes in Cardiovascular Autonom Neuropathia Type-2 Dm Whit Spinal Anesthesia

Status unknown Last updated 12 March 2019
What this trial tests

trial testing perfusion index monitor in Anesthesia; Adverse Effect in 240 participants. Status unknown.

Timeline
1 December 2017
Primary endpoint
1 December 2020
1 December 2020

Quick facts

Lead sponsorErzincan University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment240
Start date1 December 2017
Primary completion1 December 2020
Estimated completion1 December 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Erzincan University

Who can join

18 and older, any sex, with Anesthesia; Adverse Effect. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cardiovascular autonomic neuropathy in diabetic patients, hypertension, sympathovagal imbalance, orthostatic hypotension, painless myocardial infarction, ischemia, left ventricular dysfunction, cardiac sympathetic and parasympathetic innervation disturbances, qt interval prolongation and sudden deaths observed. The purpose of this study is to evaluate the relationship between cardiovascular autonomic neuropathy and perfusion index in spinal anesthesia

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Anesthesia; Adverse Effect

Currently open trials in the same condition.

Other Erzincan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03869775.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing